João Eduardo Izaias

João Eduardo Izaias

Auto-generated profile, based on publicly available information

João Eduardo Izaias

D'Or Institute for Research and Education (IDOR)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Hypertension
Verified
Journal Article
Closed access
PDF file
DFDiego Faria
Diego Faria
RMRenata Moll-Bernardes
Renata Moll-Bernardes
LTLaura Testa
Laura Testa
CMCamila M.V. Moniz
Camila M.V. Moniz
ERErika C. Rodrigues
Erika C. Rodrigues
ASAllan R.K. Sales
Allan R.K. Sales
Background: COVID-19 has become a dramatic health problem during this century. In addition to high mortality rate, COVID-19 survivors are at increased risk for cardiovascular diseases 1-year after infection. Explanations for these manifestations are still unclear but can involve a constellation of biological alterations. We hypothesized that COVID-19 survivors compared with controls exhibit sympathetic overdrive, vascular dysfunction, cardiac morpho-functional changes, impaired exercise capacity, and increased oxidative stress. Methods: Nineteen severe COVID-19 survivors and 19 well-matched controls completed the study. Muscle sympathetic nerve activity (microneurography), brachial artery flow-mediated dilation and blood flow (Doppler-Ultrasound), carotid-femoral pulse wave velocity (Complior), cardiac morpho-functional parameters (echocardiography), peak oxygen uptake (cardiopulmonary exercise testing), and oxidative stress were measured ~3 months after hospital discharge. Complementary experiments were conducted on human umbilical vein endothelial cells cultured with plasma samples from subjects. Results: Muscle sympathetic nerve activity and carotid-femoral pulse wave velocity were greater and brachial artery flow-mediated dilation, brachial artery blood flow, E/e′ ratio, and peak oxygen uptake were lower in COVID-19 survivors than in controls. COVID-19 survivors had lower circulating antioxidant markers compared with controls, but there were no differences in plasma-treated human umbilical vein endothelial cells nitric oxide production and reactive oxygen species bioactivity. Diminished peak oxygen uptake was associated with sympathetic overdrive, vascular dysfunction, and reduced diastolic function in COVID-19 survivors. Conclusions: Our study revealed that COVID-19 survivors have sympathetic overactivation, vascular dysfunction, cardiac morpho-functional changes, and reduced exercise capacity. These findings indicate the need for further investigation to determine whether these manifestations are persistent longer-term and their impact on the cardiovascular health of COVID-19 survivors.

1 July 2025 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
BOBruna E. Ono
Bruna E. Ono
JIJoão E. Izaias
João E. Izaias
ASArtur O. Sales
Artur O. Sales
TRThais S. Rodrigues
Thais S. Rodrigues
CNCamila S. Nunes
Camila S. Nunes
ASAllan R. K. Sales
Allan R. K. Sales
Patients with long COVID, even 2 yr after SARS-CoV-2 infection, exhibited sympathetic neural overdrive, aortic stiffening, endothelial dysfunction, cardiac morphofunctional changes, diminished aerobic exercise capacity, increased circulating endothelial cell-derived EVs, decreased antioxidant activity, and increased oxidant activity. Moreover, we showed that the reduced aerobic exercise capacity was associated with sympathetic neural outflow, vascular dysfunction, cardiac morphofunctional alterations, and increased circulating oxidative stress.

1 December 2018 in Revista Brasileira de Medicina do Esporte
Verified
Journal Article
Open access
PDF file
BNBruno Do Nascimento-Carvalho
Bruno Do Nascimento-Carvalho
MMMiguel Angel Condori Mayta
Miguel Angel Condori Mayta
JIJoão Eduardo Izaias
João Eduardo Izaias
MDMarcio Roberto Doro
Marcio Roberto Doro
KSKatia Scapini
Katia Scapini
Iris Callado SanchesIris Callado Sanches
Iris Callado Sanches
Introduction: Although the rapid weight loss process is undertaken by combat sports athletes very often, the impact of this practice on cardiovascular health is not fully understood. Objective: To verify the effects of the rapid weight loss process undertaken by combat sports athletes on hemodynamic parameters, cardiovascular autonomic modulation and mood state. Methods: Eight male fighters (21.62±1.49 years, 71.25±3.54 kg, 1.74±0.03 cm) were assessed in the city of São Paulo. The subjects had 5.37±0.77 years of practice and were training 5.75±0.45 days per week, for 3.05±0.69 hours per day. The athletes were assessed on 2 occasions: 14 days before and 1 day before official weigh-in. Weight, height and bioimpedance were used for body composition analysis. Mood state was assessed using the Brums Mood Scale. Blood pressure was measured at rest with a digital meter. Cardiovascular autonomic modulation was obtained through an analysis of heart rate variability recorded for 25 minutes at rest. The Student's t-test for dependent samples was used for comparison between time points. Values of p<0.05 were considered significant. Results: No differences in body composition were observed between the time points evaluated. After the weight loss strategy, increases in mood state parameters related to anger, vigor and fatigue categories were observed. Blood pressure did not change between the time points evaluated. However, an increase in heart rate associated with greater sympathetic modulation was observed after the weight loss strategy. There were no differences in autonomic modulation parameters representing parasympathetic activity. Conclusions: The study provided evidence of a higher cardiovascular risk in athletes as a result of this rapid weight loss practice, which is very concerning since combat sports athletes repeat this process several times during their lives. Level of Evidence IV; Study type: Case series.

17 March 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
JIJoão E. Izaias
João E. Izaias
ASArtur O. Sales
Artur O. Sales
BOBruna E. Ono
Bruna E. Ono
TRThais S. Rodrigues
Thais S. Rodrigues
GSGabrielly M. P. S. Silva
Gabrielly M. P. S. Silva
ASAllan R. K. Sales
Allan R. K. Sales
Background: Long‐term survivors of breast cancer (BC) treated with doxorubicin and trastuzumab‐based chemotherapy are at increased risk of developing cardiovascular disease. However, the physiological mechanisms associated with increased cardiovascular disease risk are completely unknown. We hypothesized that long‐term survivors of BC, compared with controls, exhibit sympathetic neural hyperactivity, vascular dysfunction, cardiac morphofunctional changes, exercise intolerance, and alterations in the circulating milieu. Methods: Twenty‐three survivors of BC (age: 48.9±1.3 years; body mass index: 25.2±0.8 kg/m 2 ) and 18 (age: 46.4±1.3 years; body mass index: 26.8±0.8 kg/m 2 ) well‐matched controls were studied. Muscle sympathetic nerve activity (microneurography), brachial artery flow‐mediated dilation (ultrasound‐Doppler), carotid‐femoral pulse wave velocity (tonometry), left ventricular ejection fraction and global longitudinal strain (echocardiography), peak oxygen uptake (cardiopulmonary exercise testing), endothelial cell‐derived extracellular vesicles (flow cytometry), and plasma metabolome (mass spectrometry) were assessed. Complementary experiments were conducted on human umbilical vein endothelial cells cultured with plasma samples from subjects. Results: Survivors of breast cancer were tested ⁓8 years after cancer treatment completion. Muscle sympathetic nerve activity was higher and brachial artery flow‐mediated dilation and peak oxygen uptake were lower in survivors than controls. Survivors of breast cancer exhibited higher circulating endothelial cell‐derived extracellular vesicles, higher reactive oxygen species bioactivity, and lower acetylcholine‐evoked nitrics oxide production in plasma‐treated human umbilical vein endothelial cells. Twenty‐eight plasma metabolites differed in survivors versus controls. Peak oxygen uptake was inversely related to muscle sympathetic nerve activity or positively to brachial artery flow‐mediated dilation. No differences in carotid‐femoral pulse wave velocity, left ventricular ejection fraction, and left ventricular global longitudinal strain were observed. Conclusions: Our findings demonstrate that long‐term survivors of breast cancer exhibit sympathetic overdrive, vascular dysfunction, and exercise intolerance, which may contribute to increased cardiovascular disease risk in this population.

7 November 2023 in Circulation
Verified
Journal Article
Closed access
JIJoao Izaias
Joao Izaias
RBRenata Bernardes
Renata Bernardes
BOBruna Ono
Bruna Ono
DFDiego Faria
Diego Faria
ASArtur Sales
Artur Sales
AKAllan Kluser
Allan Kluser
Introduction: Previous evidence demonstrates that breast cancer (BC) survivors who were treated with doxorubicin and trastuzumab-based chemotherapy have an increased risk of developing cardiovascular (CV) disease at least 7 years after completion of cancer treatment. The reasons for the increased CV disease risk are not completely understood, a constellation of physiological changes may contribute. We hypothesized that BC survivors compared with age- and body mass index (BMI), sex -matched healthy controls, exhibit sympathetic neural overactivity, vascular endothelial dysfunction, aortic stiffening, and diminished exercise capacity. Methods: Twelve women BC survivors, treated with doxorubicin and trastuzumab (age=48±2 years and BMI=28±2 Kg/m 2 ) and fourteen women control subjects (age=46±1 years and BMI=27±1 Kg/m 2 ) were studied. Muscle sympathetic nerve activity (MSNA, Microneurography), endothelium-dependent dilation (brachial artery flow-mediated dilation, BAFMD), aortic stiffness (carotid-femoral pulse wave velocity, CFPWV), blood pressure (BP, Finometer), heart rate (HR, Electrocardiogram), and peak oxygen uptake (V˙O 2 peak, Cardiopulmonary exercise testing) were measured. Results: BC survivors were evaluated 8±2 years after the completion of cancer treatment. Burst frequency and burst incidence of MSNA were higher and BAFMD and V˙O 2 peak were lower in BC survivors than in controls ( p 0.05). MSNA burst frequency and burst incidence were inversely associated with V˙O 2 peak or BAFMD ( p <0.05). Conclusion: Our findings demonstrate that BC survivors have an augmented sympathetic neural activity, endothelial dysfunction, and attenuated exercise capacity, which may help to explain, at least in part, the increased CV risk in this population. Therefore, it is urgent to establish therapeutic strategies (e.g., physical exercise rehabilitation) to restore or alleviate these cardiovascular changes in BC survivors.

1 June 2026 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
JIJoão E. Izaias
João E. Izaias
BOBruna E. Ono
Bruna E. Ono
ASArtur O. Sales
Artur O. Sales
TRThais S. Rodrigues
Thais S. Rodrigues
GSGabrielly M. P. S. Silva
Gabrielly M. P. S. Silva
ASAllan R. K. Sales
Allan R. K. Sales
Long-term breast cancer (BC) survivors previously treated with doxorubicin- and trastuzumab-based chemotherapy show reduced muscle metaboreflex activation, which partly explains attenuated pressor and sympathetic neural responses to exercise in this population. Importantly, these findings shed light on the blunted exercise-induced blood pressure increase observed in long-term BC survivors.